Petmed Express (PETS) Current Deferred Revenue (2023 - 2025)

Petmed Express has reported Current Deferred Revenue for 3 years, with the latest figure at $800000.0 in Q4 2025.

• For the quarter ending Q4 2025, Current Deferred Revenue fell 33.33% year-over-year to $800000.0; the trailing twelve-month figure through Dec 2025 stood at $800000.0 (down 33.33% YoY), and the FY2025 full-year result was $2.1 million, down 19.23% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $800000.0, down from $1.0 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $3.6 million in Q3 2023, with the low at $800000.0 in Q4 2025.
• Historically, Current Deferred Revenue has averaged $2.0 million across 3 years, with a median of $2.1 million in 2024.
• Annual changes were most pronounced in 2024 — Current Deferred Revenue slumped 60.89% — and 2025, when it retreated 19.23%.
• Petmed Express' Current Deferred Revenue stood at $3.1 million in 2023, then plunged by 60.89% to $1.2 million in 2024, then plunged by 33.33% to $800000.0 in 2025.
• The last three Current Deferred Revenue figures came in at $800000.0 (Q4 2025), $1.0 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.